Purpose
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment | Radiation Oncology | Full Text
Stage Shift Improves Lung Cancer Survival: Real-World Evidence - Journal of Thoracic Oncology
The prognosis of non-small cell lung cancer patients according to endobronchial metastatic lesion | Scientific Reports
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis | PLOS ONE
Cancers | Free Full-Text | Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer
Overall survival of 1466 non-small cell lung cancer patients according... | Download Scientific Diagram
Education & Resources for Oncology Nurses – IMFINZI® (durvalumab)
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug - ScienceDirect
Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer | British Journal of Cancer
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer
Histological Grade: Analysis of Prognosis of Non-small Cell Lung Cancer After Complete Resection | In Vivo
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis - The Lancet Oncology
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer | NEJM
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology
File:Overall survival in non-small lung cancer patients treated with modern immunotherapy in the first line for advanced or metastatic disease.jpg - Wikimedia Commons
Non-Small Cell Lung Cancer
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
Cancers | Free Full-Text | Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre
Overall survival curves of patients with lung cancer. The 5-year... | Download Scientific Diagram
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis | Radiation Oncology | Full Text
VA Studies Provide Insight Into Improving Survival in Small Cell Lung Cancer - U.S. Medicine
Overall survival by clinical stage according to the seventh edition (A)... | Download Scientific Diagram
LIBTAYO® (cemiplimab-rwlc) Overall Survival Rate in Advanced NSCLC
Surgery soon after clinical staging of non-sm | EurekAlert!
Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer | European Respiratory Society
